Showing results (151-160 of 185) with videos related to
Sort By:
Pageof 19
Journal of Medicinal Chemistry|April 5, 2011
Highly improved metabolic stability and pharmacokinetics of indium-111-DOTA-gastrin conjugates for targeting of the gastrin receptorPetra Kolenc-Peitl, Rosalba Mansi, MariaLuisa Tamma, et al.Journal of Medicinal Chemistry|March 9, 2018
New Gastrin Releasing Peptide Receptor-Directed [<sup>99m</sup>Tc]Demobesin 1 Mimics: Synthesis and Comparative EvaluationBerthold A Nock, David Charalambidis, Werner Sallegger, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 18, 2011
PET of somatostatin receptor-positive tumors using 64Cu- and 68Ga-somatostatin antagonists: the chelate makes the differenceMelpomeni Fani, Luigi Del Pozzo, Keelara Abiraj, et al.Chemistry & Biodiversity|December 12, 2013
Syntheses, receptor bindings, in vitro and in vivo stabilities and biodistributions of DOTA-neurotensin(8-13) derivatives containing β-amino acid residues - a lesson about the importance of animal experimentsChristof Sparr, Nirupam Purkayastha, Tomohiro Yoshinari, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 4, 2006
Internalization of sst2, sst3, and sst5 receptors: effects of somatostatin agonists and antagonistsRenzo Cescato, Stefan Schulz, Beatrice Waser, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 18, 2005
Molecular imaging as in vivo molecular pathology for gastroenteropancreatic neuroendocrine tumors: implications for follow-up after therapyEric P Krenning, Roelf Valkema, Dik J Kwekkeboom, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2007
[Lys40(Ahx-DTPA-111In)NH2]-Exendin-4 is a highly efficient radiotherapeutic for glucagon-like peptide-1 receptor-targeted therapy for insulinomaAndreas Wicki, Damian Wild, Daniel Storch, et al.Theranostics|March 1, 2014
Positron emission tomography (PET) imaging of prostate cancer with a gastrin releasing peptide receptor antagonist--from mice to menGesche Wieser, Rosalba Mansi, Anca L Grosu, et al.Molecular Pharmaceutics|July 2, 2015
Copper-64 Labeled Macrobicyclic Sarcophagine Coupled to a GRP Receptor Antagonist Shows Great Promise for PET Imaging of Prostate CancerEleni Gourni, Luigi Del Pozzo, Emilie Kheirallah, et al.EJNMMI Research|August 3, 2018
The tetraamine chelator outperforms HYNIC in a new technetium-99m-labelled somatostatin receptor 2 antagonistKeelara Abiraj, Samer Ursillo, Maria Luisa Tamma, et al.Pageof 19